Welcome
Support Centre
25 July 2008 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Zhongshan angle-closure prevention study
ISRCTN ISRCTN45213099
ClinicalTrials.gov identifier
Public title Zhongshan angle-closure prevention study
Scientific title A randomised controlled trial of prevention of angle-closure glaucoma in China
Acronym ZAAP
Serial number at source 1
Study hypothesis That laser iridotomy helps to prevent primary angle-closure (a major risk factor for glaucoma) in Chinese adults aged 50 years and older.
Ethics approval Ethics approval received from:
1. Ethical Review Board of Zhongshan Ophthalmic Centre (China) in November 2002
2. London School of Hygiene and Tropical Medicine (UK) on the 17th March 2008 (ref: 5267)
Study design Single-centre, randomised, controlled trial (not masked)
Countries of recruitment China
Disease/condition/study domain Angle-closure glaucoma
Participants - inclusion criteria 1. Anatomically narrow drainage angles in the anterior segment of the eye
2. No evidence of primary angle-closure (high pressure or peripheral anterior synechiae)
3. Aged greater than or equal to 50 years
Participants - exclusion criteria 1. Inability or unwillingness to give informed consent
2. Raised intraocular pressure, peripheral anterior synechiae or glaucomatous optic neuropathy
3. Previous intraocular surgery
Anticipated start date 01/03/2008
Anticipated end date 28/02/2011
Status of trial Ongoing
Patient information material Not available in web format, please use the contact details below to request a patient information sheet (available in Chinese with English translation upon request)
Target number of participants 1,100
Interventions The right and left eyes of each participant will be randomly allocated to the intervention treatment or no treatment (control).

Intervention treatment: Laser iridotomy by sequential argon then Nd:YAG laser. Duration of the laser treatment is about 5 minutes.
Control: No intervention (current standard treatment only)

Each participant will be examined at baseline, 2 weeks, 6, 18, 30 and 42 months.
Primary outcome measure(s) The following will be assessed on each of the scheduled follow-up (6, 18, 30 and 42 months):
1. Raised intraocular pressure (either with or without symptoms). Intraocular pressure greater than 24 mmHg verified on two consecutive measurements on separate days. These patients will be further identified as having open, partially-closed or completely closed angles on dark room gonioscopy and anterior segment optical coherence tomography (AS-OCT).
2. Peripheral anterior synechiae
3. Glaucomatous optic neuropathy

If participants are felt to have met a failure criterion, we will re-assess (by examination with one of the senior investigators) within the next 2 weeks to confirm. The failure will then be classified as having occurred at 6, 18, 30 or 42 months (end of the study).
Secondary outcome measure(s) The following will be assessed on each of the scheduled follow-up (6, 18, 30 and 42 months):
1. Specular microscopy measures of corneal endothelial cell loss
2. Formation of lens opacity
3. Anterior segment optical coherence tomography measures (qualitative and quantitative) of ocular anterior segment anatomy

If participants are felt to have met a failure criterion, we will re-assess (by examination with one of the senior investigators) within the next 2 weeks to confirm. The failure will then be classified as having occurred at 6, 18, 30 or 42 months (end of the study).
Sources of funding 1. Fight for Sight (UK) - Project grant
2. Sun Yat-Sen University (China) - Clinical Research 5010 (ref: 2007033)
3. Ministry of Education (China) - Programme Grant for Outstanding University Researchers (ref: NCET 06 0720)
Trial website
Publications
Contact name Dr  Paul  Foster
  Address University College London
Institute of Ophthalmology
11-43 Bath Street
  City/town London
  Zip/Postcode EC1V 9EL
  Country United Kingdom
  Tel +44 (0)20 7608 6899
  Fax +44 (0)20 7608 4012
  Email p.foste@ucl.ac.uk
Sponsor University College London (UK)
  Address Gower Street
  City/town London
  Zip/Postcode WC1E 6BT
  Country United Kingdom
  Tel +44 (0)20 7608 6854
  Fax +44 (0)20 7608 6954
  Email h.jones@ucl.ac.uk
  Sponsor website: http://www.ucl.ac.uk/
Date applied 16/01/2008
Last edited 06/05/2008
Date ISRCTN assigned 06/05/2008
Submit your trial protocol Top studies in medical research Submit to Trials journal
© ISRCTN


BioMed Central